1. A procedure is described for the purification of leucine dehydrogenase (EC 1.4.1.9) from Bacillus subtilis. 2. The preparation is suitable for the quantitative assay of branched-chain amino acids and their 2-oxoacid analogues. 3. The content of total branched-chain 2-oxoacids in freeze-clamped liver, kidney, heart or mammary gland of fed rats is less than 5 nmol/g fresh wt. Higher amounts are present in skeletal muscle and arterial blood (25 +4nmol per g fresh wt., and 33 ± 6nmol per ml respectively; means + S.D. of 3 and 11 animals respectively). The values are not significantly affected by starvation for 24 h. 4. Arteriovenous difference measurements show that considerable amounts of branched-chain 2-oxoacids are released by skeletal muscle into the circulation and similar amounts are removed by the liver (about 1 mmol/24 h in a 400 g rat).
It is generally accepted that muscle is the main site of transamination of the branched-chain amino acids, but whether complete oxidation of their 2-oxoacids also occurs in muscle in vivo is still an open question. The 2-oxoacids may be oxidized to provide the carbon skeleton of either alanine (Davis & Bremer, 1973; Goldstein & Newsholme, 1976; Garber et al., 1976; Spydevold, 1976; Snell & Duff, 1977) or glutamine (Chang & Goldberg, 1978a,b) released by skeletal muscle. Nevertheless, the high activity of the branched-chain 2-oxoacid dehydrogenase and low activity-of the aminotransferase in liver, compared with skeletal muscle, has led to the suggestion that the 2-oxoacids are transferred to the liver for oxidation (Wohlhueter & Harper, 1970; Krebs & Lund, 1977) . The main obstacle to settling this problem has been the lack of a sensitive, reliable assay for the branched-chain 2-oxoacids. Because of this we have purified a leucine dehydrogenase (EC 1.4.1.9) from a strain of Bacillus subtilis for the quantitative determination of leucine, isoleucine and valine and their 2-oxoacid analogues in tissue extracts. The results show a release of branchedchain 2-oxoacids from the hindlimb and an uptake by the liver under physiological conditions in the rat. However, the possibility that some oxidation of the 2-oxoacids occurs also in skeletal muscle in vivo is not ruled out.
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Materials and Methods
Bacillus subtilis (N.C.I.B. no. 8577) originated from the National Collection of Industrial Bacteria. Powdered yeast extract and dextrose peptone broth were from Oxoid, Wade Road, Basingstoke, Hants., U.K. Silicone MS antifoam A was from Hopkins & Williams, Chadwell Heath, Essex, U.K. Pig heart lactate dehydrogenase (EC 1.1.1.27), NAD+ (grade I), NADH (grades I and II), L-malic acid, sodium DL-3-hydroxybutyrate, sodium pyruvate, oxaloacetic acid and disodium 2-oxoglutarate were from Boehringer. Lysozyme (grade I), DEAE-cellulose (medium mesh), , L-leucine (Sigma grade), L-valine, L-isoleucine (Sigma grade), L-methionine, L-alanine, sodium 4-methyl-2-oxovalerate ('oxoleucine') and glyoxylic acid were products of Sigma. Other amino acids were of the highest purity available from either BDH or Sigma. Sodium salts of 3-methyl-2-oxobutyric acid ('oxovaline'), 3-methyl-2-oxovaleric acid ('oxoisoleucine'), phenylpyruvic acid and 4-methylthio-2-oxobutyric acid ('oxomethionine') were a gift from Dr. Acetoacetate was prepared from ethyl acetoacetate as described by Williamson et al. (1962) . Calcium phosphate gel, precipitated on cellulose powder, was prepared by the method of Koike & Hamada (1971 Subsequent procedures for the purification of the leucine dehydrogenase were performed at 0-40C unless otherwise stated and all buffer solutions contained 0.01% (v/v) 2-mercaptoethanol. (NH4)2SO4 extraction. After addition of 0.05 vols.
of 1 M-MnSO4 to the crude extract containing the nucleic acids, the precipitate was removed after 5min by centrifugation. Powdered (NH4)2SO4 was added to the supernatant to give 45% saturation. The precipitate formed after 1 h was removed by centrifugation and the supernatant made 70% satd. with powdered (NH4)2SO4. After 1 h the precipitate formed was collected by centrifugation, dissolved in 50ml of 0.O1M-KH2PO4, adjusted to pH7.4 with NaOH, and dialysed against 100vol. of the same buffer for 16h. The supernatant obtained after centrifugation of the dialysis residue gave the '(NH4)2SO4 fraction'.
Calcium phosphate gel chromatographv. A calcium phosphate-gel bed (10cm diam. x 4cm) was prepared in a Buchner funnel after dilution of the calcium phosphate gel with cellulose powder (see Koike & Hamada, 1971 Assay ofleucine dehydrogenase The standard reaction mixture for oxidative deamination was adapted from that described by Lund & Baverel (1978) for the assay of alanine dehydrogenase. The reaction cuvette contained, at 25°C: 1.Oml of 0.1 M-Na2CO3 buffer, pH 10.0, containing 2 mM-EDTA, 0.1 ml of 2% (w/v) NAD+, substrate solution and water to 2.0ml. The reaction was started with 0.02ml of appropriately diluted enzyme solution. Blanks contained water in place of the substrate solution.
The assay system for reductive amination was essentially that of Ohshima et al. (1978a Alanine dehydrogenase and glutamate dehydrogenase were each assayed by the method already described for leucine dehydrogenase with alanine or glutamate respectively as substrates. The methods used for the assay of both lactate dehydrogenase and malate dehydrogenase, using pyruvate and oxaloacetate respectively as substrates, were as described by Yoshida & Freese (1964) .
Assay ofbranched-chain amino acids
Assays were performed at room temperature in reaction cuvettes containing: 1.0 ml of 0.1 M-Tris/ HCl, pH 9.0, containing 2.0% (v/v) hydrazine hydrate and 2mM-EDTA; 0.1 ml of 2% NAD+, sample and water to 2.0 ml. The reaction was started with 1 unit of leucine dehydrogenase (0.02 ml) that had been partially freed from (NH4)2SO4 by centrifugation of the enzyme suspended in 75% satd. (NH4)2SO4 and resuspending the pellet in 0.01 M-K2HPO4/KH2PO4, pH 7.2, containing 0.01% (v/v) 2-mercaptoethanol. Blanks contained water in place of substrate. The progress of the reaction was followed to completion at 340 nm. The time taken was 30-45 min with pure solutions and 1.5-2h with tissue extracts.
Assay ofbranched-chain 2-oxoacids
Assays were performed at room temperature in reaction cuvettes that contained: 1.0 ml of 0.1 MTris/HCl, pH 8.5, containing 2mM-EDTA; 0.2 ml of IM-NH4CI; 0.1 ml of 0.3% NADH (grade II); sample and water to 2.0 ml. The reaction was started Vol. 188 with 0.75 units (0.0 15 ml) of leucine dehydrogenase suspended in 75% satd. (NH4)2SO4. Blanks contained water in place of substrate solution. The progress of the reaction was followed to completion at 340nm using either a Zeiss spectrophotometer or, for tissue extracts, an Aminco DW2 split-beam spectrophotometer connected to a chart recorder; the noise level was +0.0002A of the recorded absorption. When the split-beam instrument was used a further 0.5 ml of buffer was included in the reaction mixture. Assays were complete within 3-5 min with pure solutions and 5-10min with tissue extracts.
When assaying the branched-chain 2-oxoacid content of neutralized tissue extracts the above procedure was modified in two ways. First, blanks contained sample solution and the enzyme solution was replaced by water and second, 0.01 ml of lactate dehydrogenase was added to both the assay and the blank mixtures, to reduce any pyruvate to lactate, before addition of leucine dehydrogenase.
Animals
Rats were kept in a 12h light-dark cycle with illumination between 08:30h and 20:30h and were fed a Labsure PRD diet (Labsure Animal Foods, Poole, Dorset, U.K.). Some animals were starved for 24h. All experiments commenced between 09:00h and 11:00 h. Mammary gland was obtained from one early-lactating and two mid-lactating female Wistar rats each weighing approx. 375g. All other tissues were obtained from male Wistar rats each weighing between 375 and 450g.
Preparation oftissue extracts
Animals were anaesthetized by intraperitoneal injection of approx. 0.1 ml of pentobarbital (60 mg/ ml) per lOOg body wt. before removing any tissue.
Blood samples (0.5-1.0ml) were withdrawn from the appropriate vessels of animals that had been previously been given approx. 0.2 ml of heparin sulphate (5000units/ml) via a femoral vein. Each sample was mixed with 1.Oml of water to lyse the erythrocytes and, after 30s, l.Oml of ice-cold 15% (w/v) HC104 was added with thorough mixing. The acid-insoluble material remaining after 20 min at 0-4°C was removed by centrifugation and a known volume of acid extract was neutralized with a measured volume of 20% (w/v) KOH. After 30min at 0(4°C the precipitate was removed by centrifugation.
When a large quantity of blood was required for a recovery experiment, blood was collected from the mid-aorta.
Plasma and washed erythrocytes were obtained as described by Marks (1966) , the erythrocytes being washed four times in Krebs-Henseleit saline (Krebs & Henseleit, 1932) and resuspended in the saline to give a normal haematocrit. Acid-soluble material was extracted from both the plasma and the erythrocyte suspension and neutralized using the same procedure as for whole blood.
Other tissues (liver, kidney, heart, skeletal muscle from the right hindquarter, and mammary gland) were taken from separate animals. Each tissue was rapidly (<20s) dissected free and frozen between large aluminium tongs previously cooled in liquid N2 (Wollenberger et al., 1960) . Frozen tissue was kept under liquid N2 until finely ground in a porcelain mortar with a pestle cooled with liquid N2. To 1.0g of the powdered tissue in a plastic centrifuge tube was added 4.0ml of ice-cold 6% (w/v) HCI04. The mixture was homogenized with a motor-driven Teflon pestle. After extraction for 30min at 0-40C the tubes were centrifuged and the supernatants neutralized as already described. The acid extracts of the mammary tissue remained turbid after centrifugation but were clarified by filtration through an 8pum Millipore filter before being neutralized.
Recovery of amino acids and 2-oxoacids in neutralized tissue extracts
To 2.0 ml of an acidic homogenate of a solid tissue, or 1.0 ml of either whole blood, plasma or erythrocyte suspension was added 0.00, 0.025, 0.05, 0.10 or 0.20,umol of a branched-chain 2-oxoacid (from a 2 mm solution) and, to the same tubes, either 0.00, 0.25, 0.5, 1.0 or 2.0,umol of the parent amino acid (from a 20 mm solution) so that the exogenous amino acid/exogenous 2-oxoacid concentration ratio was always 10:1 (i.e. similar to the ratio in rat blood). Whole blood, plasma and erythrocyte suspensions were made up to 2.0ml with water and deproteinized with 1.0ml of ice-cold 15% (w/v) HC104. After complete mixing and centrifugation a measured volume of supernatant was neutralized with a known volume of KOH. All were assayed for branched-chain amino acid and 2-oxoacid content. Percentage recoveries were calculated after correction for the endogenous values.
Results

Purity ofthe leucine dehydrogenase preparation
The specific activity of the dehydrogenase increased 85-fold during the purification procedure (see Table 1 ). The purity of the preparation was determined from its enzymic activities toward substrates likely to be present in tissue extracts. Physical criteria were not employed. Several other nicotinamide-nucleotide-linked dehydrogenases are associated with B. subtilis: alanine, glutamate, lactate and malate dehydrogenase. Except for alanine dehydrogenase, the activities of these enzymes were low in crude extracts derived from strain 8577 and were not measurable in the final enzyme preparation. A large proportion (99%) of the alanine dehydrogenase was removed by calcium-phosphategel chromatography in the 0.015 M-and 0.02 Mphosphate fractions. The activity of the final enzyme preparation with 10mM-alanine was 0.23% of that with 10mM-leucine.
Kinetic properties ofthe enzyme preparation
Oxidative deamination of leucine, isoleucine and valine readily occurred at pH 10.0; Michaelis constants, obtained by Lineweaver-Burk plots with the reaction system containing 1.5 mM-NAD+, were 1.3, 2.4 and 3.4mm respectively. Reductive amination of the branched-chain 2-oxoacids at pH9.5 occurred more rapidly than the oxidative deamination of the corresponding amino acids. Michaelis constants, obtained by Lineweaver-Burk analysis, in reaction systems containing 0.2 mM-NADH were 0.6, 0.9 and 3.3mm for 4-methyl-2-oxovalerate, 3-methyl-2-oxovalerate and 3-methyl-2-oxobutyrate respectively.
Methionine and 4-methylthio-2-oxobutyrate were also substrates, but were poor compared to the branched-chain amino acids and 2-oxoacids. Michaelis constants of 25 and 6.7mm were obtained for methionine and 4-methylthio-2-oxobutyrate, respectively. Ohshima et al. (1978a) reported that methionine was a substrate for the B. sphaericus enzyme and we found this enzyme (a gift from Professor K. Soda, Kyoto University of Education, Japan) also to ing that the activities with methionine and 4-methylthio-2-oxobutyrate are those of the leucine dehydrogenase and not a contaminating enzyme. Moreover, the rate of reductive amination of 2.5 mM-4-methyl-2-oxovalerate remained between 3.0 and 3.2-fold that of 2.5 mM-4-methylthio-2-oxobutyrate throughout the purification procedure, and the methionine dehydrogenase activity was lost upon dialysis of the preparation against distilled water, a procedure that destroys the activity of leucine dehydrogenase (Lund & Baverel, 1978) . Assay of branched-chain amino acids and 2-oxoacids in pure solution The end-point assay of L-leucine and 4-methyl-2-oxovalerate over the range tested (up to 0.2 mM final concentration in the cuvette) gave 99% oxidative deamination of leucine and 96% reductive amination of 4-methyl-2-oxovalerate. The same results were obtained when either L-isoleucine or L-valine replaced L-leucine in the assay system. Moreover, when all three amino acids were present at the same time, the quantity of NADH formed was additive. Analogous results were obtained for the 2-oxoacids.
Assays of 0.1 pmol of L-leucine and 0. lmol of 4-methyl-2-oxovalerate were performed in the presence of higher concentrations of several metabolites known to occur in biological samples. Alanine, when present at a molar concentration five times that of the leucine, had no effect on the quantity of the branched-chain amino acid found but higher concentrations resulted in an overestimation, presumably due to the contamination of the enzyme preparation with alanine dehydrogenase. Similarly, methionine, when at a concentration higher than the molar concentration of leucine, caused an overestimation of the branched-chain amino acid present. Branched-chain 2-oxoacids could not be accurately measured in the presence of an equal quantity of either pyruvate or 4-methylthio-2-oxobutyrate unless these metabolites were first converted to either lactate or 2-hydroxy-4-methylthiobutyrate by the addition of lactate dehydrogenase.
The following substrates were without effect on the end-point of the assay of 0. lmol of either L-leucine or 4-methyl-2-oxovalerate when present in the reaction cuvette at 10-fold higher concentration:
lactate, L-malate, oxaloacetate, glyoxylate, acetoacetate, DL-3-hydroxybutyrate, phenylpyruvate and 2-oxoglutarate. In addition, 10-fold greater molar concentrations of 4-methyl-2-oxovalerate, 3-methyl-2-oxovalerate, 3-methyl-2-oxobutyrate and 4-methylthio-2-oxobutyrate did not affect the endpoint of the assay of leucine. Leucine, isoleucine, valine, methionine and alanine were without effect on the end-point of the assay of 4-methyl-2-oxovalerate.
Assay of branched-chain amino acids and 2-oxoacids in biological samples Difficulties were encountered in attempting to determine the very low quantities of branched-chain 2-oxoacid present in neutralized tissue extracts when using reagent blanks in which sample was replaced by an equal volume of water. This was due to an apparent slow non-enzymic oxidation of NADH by the added neutralized tissue extract. Generally the rate of this change did not exceed 0.001 A/min when 0.5ml of neutralized tissue-extract was added to 2.0ml of the pH8.5 assay mixture. The rate was virtually constant over a 20min period and was very reproducible for individual neutralized tissue extracts, so the difficulty was easily overcome by using a reagent blank that included an equal portion of the sample with water replacing the enzyme solution. Such assays were performed using a split-beam spectrophotometer that automatically subtracted the substrate blank. Fortunately, either no change or a negligible change in absorption of the pH9.0 assay mixture occurred on addition of neutralized tissueextract, even when NADH was present; thus the above problem did not extend to the assay of branched-chain amino acids.
The accuracy of the enzymic assay of branchedchain amino acids was tested by making a comparison with an automated aminoacid analyser in the same neutral extracts from three samples of whole blood. The value obtained by enzyme analysis was 101.2 + 3.6% (mean + S.D.) of that obtained by automated amino acid analysis. Recovery of branched-chain amino acids and 2-oxoacids in rat tissues Table 2 shows the proportions of exogenous branched-chain amino acid and 2-oxoacid recovered after addition to tissue suspensions in HCl04. For each tissue, recovery of amino acids was virtually 100%. This was not so for the 2-oxoacids. Except for plasma and washed erythrocytes, the proportion of 2-oxoacids recovered from the individual tissues was remarkably constant. The proportion recovered was, except in the erythrocyte suspensions, independent of the quantity of exogenous substrate added to the HCl04 suspension. In subsequent calculations the measured amounts of branched-chain 2-oxoacids 103%. This confirms that loss into the protein precipitate occurred and was not the result of incomplete reductive amination in the assay system. This conclusion was borne out by the fact that further addition of 0.1 ,umol of 4-methyl-2-oxovalerate to the cuvette gave an increment equivalent to 100% reductive amination. No correction was necessary for plasma (Table 2) , where recovery was almost 100%. This suggests that the 2-oxoacids are stable under the conditions used to separate plasma from whole blood, and during the preparations of tissue extracts. This was confirmed experimentally: no loss occurred on storage of 2-oxoacid solutions for 48h at either 0-4°C or 20-250C in either neutral solution or in 5% (w/v) HC104. Branched-chain amino acid and 2-oxoacid contents ofrat tissue Table 3 shows values obtained by the enzymic assay of both branched-chain amino acid and 2-oxoacid contents of the different tissues of the fed and 24 h starved rat. The observed tissue levels of the amino acids indicate that essentially no concentration gradient exists between whole blood, or plasma, and skeletal muscle, heart and mammary gland. Branched-chain amino acid content of both liver and kidney was greater than in the circulation. After starvation for 24h no change in concentration of branched-chain amino acids occurred in whole blood, skeletal muscle and heart whereas decreases occurred in liver and possibly in kidney. The Table 3 . Branched-chain amino acid and 2-oxoacid content of whole blood, plasma and freeze-clamped tissues from fed and 24 h-starved rats
Values for 2-oxoacids in whole blood and for solid tissues were corrected for their 77 and 80% recovery respectively (see text and 
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branched-chain 2-oxoacid content of arterial whole blood (and plasma) appeared to be about 50% higher than in skeletal muscle taken from the hindquarter. The latter were the only tissues containing substantial quantities of the 2-oxoacids. Liver, kidney, heart and mammary gland contained either no detectable, or very small amounts of, branched-chain 2-oxoacids compared to blood. The branched-chain 2-oxoacid content of whole blood and skeletal muscle was not affected by 24 h starvation.
Arteriovenous differences in the concentrations of branched-chain 2-oxoacids
In Table 4 are shown the concentrations of branched-chain 2-oxoacids in whole blood taken from afferent and efferent vessels of the gut, liver, right kidney and the right hindquarter (skeletal muscle). Concentration differences were measured across organs of individual rats so that 'paired' values were obtained. This was necessary since the branchedchain 2-oxoacid content, even of arterial blood, varied considerably from one rat to another. Concentration differences were observed between the aorta and femoral vein and the hepatic portal vein and hepatic vein. Both were approx. 0.02,umol/ ml, in the direction of release from skeletal muscle and uptake by the liver. Although flow rates were not measured, the hepatic portal vein-hepatic vein differences represented a true arteriovenous difference because the paired aorta-hepatic portal vein differences were effectively zero (Table 4) ; the gut neither adds to nor removes from the circulation a net amount of branched-chain 2-oxoacid. The aorta-renal vein difference in concentration of branched-chain 2-oxoacid was about one-tenth that across the liver; small quantities of the branchedchain 2-oxoacids may be removed from the circulation by the kidney.
Discussion
Application of leucine dehydrogenase to the assay of branched-chain amino acids and 2-oxoacids in tissue extracts
This work follows the observation of Lund & Baverel (1978) that commercial preparations of alanine dehydrogenase from B. subtilis are contaminated to varying extents with a branched-chain amino acid dehydrogenase. This enzyme has now been induced in a B. subtilis strain by growing the organism in a leucine-rich medium. It seemed logical to use a strain of this organism because of the possibility that both alanine dehydrogenase and leucine dehydrogenase could be isolated commercially from the same culture of B. subtilis.
It was not our aim to isolate a crystalline leucine dehydrogenase: this had already been achieved by Hermier et al. (1970) and Soda et al. (1971) . We set out to devise a relatively simple procedure that would yield an enzyme preparation suitable for the assay of branched-chain amino-and 2-oxoacids in tissue extracts. As far as we are aware, this is the first time that enzymic analysis has been used for the assay of these metabolites in biological materials. The enzyme from B. sphaericus has been applied only to their assay in pure solution (Ohshima et al., 1978b) . The enzymic assay of branched-chain 2-oxoacids has the advantage that it is very quick, but, unlike the g.l.c. method of Cree et al. (1979) , it does not distinguish between the three 2-oxoacids.
Kinetic properties ofleucine dehydrogenase
The kinetic properties of the enzyme are similar to those reported for leucine dehydrogenase isolated from B. sphaericus and sporulating B. subtilis. Our Km values are 1.3, 2.4 and 3.3 mm for leucine, isoleucine and valine compared with 1.0, 1.8 and 1.7mm respectively for the B. sphaericus enzyme (Ohshima et al., 1978a ) and 1.2, 1.3 and 3.9mM res- Hermier et al. (1970) . For the reverse reaction the corresponding values for 4-methyl-2-oxovalerate and 3-methyl-2-oxobutyrate are 0.6 and 3.3 mM; 0.31 and 1.4mM (Ohshima et al., 1978a) ; 0.83 and 1.9mM (Hermier et al., 1970) respectively. These values are generally lower than those obtained by Zink & Sanwal (1962) (Munro & Fleck, 1969; Adibi, 1971) . The finding that 24h starvation has little effect on branched-chain amino acid concentrations in rat tissues, except to decrease the liver content, is consistent with the observations of Adibi ( 1971) .
The apparent concentrations of the branchedchain 2-oxoacids are extremely low in liver, kidney and heart, compared to the plasma concentration, and below the Km for the enzyme (branched-chain 2-oxoacid dehydrogenase, EC 1.2.4.4) catalysing their oxidative decarboxylation in these tissues. The Km for each of the three 2-oxoacids range from 10-15pM (Parker & Randle, 1978) and 30-35pM (Danner et al., 1978) for the rat-liver enzyme; 37-50,UM for the bovine kidney enzyme (Pettit et al., 1978) and 14.5,UM for 4-methyl-2-oxovalerate in the rat-heart complex (Parker & Randle, 1980) . This suggests that substrate availability is one factor determining flux through the dehydrogenase complex in these tissues in vivo. Of these tissues, liver removes large amounts of the 2-oxoacids from the circulation. As the liver has a very limited capacity to form the 2-oxoacids, regulation by substrate availability in this tissue must be exerted primarily by the rate of transfer of the 2-oxoacids across the plasma membrane.
In skeletal muscle, in contrast to the other tissues examined, the 2-oxoacid content is close to the plasma concentration, and 2-oxoacids are released into the circulation. This means that branched-chain 2-oxoacid dehydrogenase is rate-limiting in this tissue, at least in fed and 24 h-starved rats; to predict for other physiological states is not possible since there may be regulation of the enzyme by phosphorylation/dephosphorylation in skeletal muscle, heart and diaphragm (Odessey & Goldberg, 1979; Parker, 1979; Parker & Randle, 1980) . Similar considerations apply to experiments in vitro with physiological concentrations of leucine in which branched-chain 2-oxoacids have been shown to be released from the perfused hind-limb (Hutson et al., 1978) and incubated soleus muscle and diaphragm (Odessey & Goldberg, 1979) .
Physiological aspects of the transfer of 2-oxoacids from muscle to liver Calculations from our data (Table 4) , on the basis of blood flow rates given by Chatwin et al. (1969) , show the amount of 2-oxoacid released by muscle of a fed 400g rat to be 0.9-1.7mmol/24h. This is almost paralleled by the calculated removal of 0.7-1.1mmol/24h by the liver. Uptake of 2-oxoacids by the liver appears to be limited by the plasma membrane since their intracellular concentration is very low compared with the circulating plasma concentration. This additional site of regulation appears to operate also in kidney, heart and mammary gland (Table 3 ) and erythrocytes (Cree et al., 1979) . Physiologically, such permeability barriers are essential: free access of branched-chain 2-oxoacids to the very active dehydrogenase in liver would result in a rapid depletion of 2-oxoacids and, through the equilibrium catalysed by the aminotransferase enzymes, the parent essential amino acids.
From these experiments we cannot determine the extent to which oxidation of branched-chain 2-oxoacids occurs in muscle. Nevertheless, transfer of 2-oxoacids to liver means their importance as a respiratory fuel of muscle is diminished. A net transfer of energy to the liver occurs even if the 2-oxoacids are used for the synthesis of glucose and ketone bodies released as fuels of respiration for other tissues.
